Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-23

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approves a supplemental application for HALOPERIDOL DECANOATE from Mylan Institutional LLC, confirming a generic long-acting injectable formulation of halop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)